DNAH11 and Miyoshi myopathy: The present study suggests that DNAH11 rs4487645 A/C genotype, ULK4 rs1052501 G/G genotype, ULK4 rs1052501 A/G genotype, DTNB rs6746082 A/A genotype, and VDR rs1544410 A/G genotype may serve as predictive biomarkers for MM risk.